{"gene":"DCHS1","run_date":"2026-04-28T17:46:02","timeline":{"discoveries":[{"year":2011,"finding":"DCHS1 functions as a ligand for FAT4 receptor in a conserved intercellular signaling pathway regulating planar cell polarity and Hippo signaling; Dchs1 and Fat4 single mutants and double mutants have similar phenotypes throughout multiple organs, and mutation of either gene increases protein staining for the other, consistent with a ligand-receptor relationship.","method":"Gene-targeted mutation in mice, phenotypic comparison of single and double mutants, protein staining","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — reciprocal genetic and protein evidence across multiple organs, replicated in multiple subsequent studies","pmids":["21303848"],"is_preprint":false},{"year":2013,"finding":"DCHS1 and FAT4 act upstream of YAP (a transcriptional effector of the Hippo signaling pathway) to regulate neural progenitor proliferation and differentiation; concurrent knockdown of Yap countered the increased progenitor numbers and reduced differentiation caused by Dchs1/Fat4 knockdown in mouse neuroepithelium.","method":"Genetic epistasis (concurrent knockdown of Yap rescues Dchs1/Fat4 loss-of-function phenotype), mouse embryonic neuroepithelium knockdown","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with clear phenotypic rescue, replicated across human and mouse models","pmids":["24056717"],"is_preprint":false},{"year":2015,"finding":"DCHS1 mutations reduce protein stability; missense mutations in DCHS1 segregating with mitral valve prolapse (MVP) result in reduced DCHS1 protein levels in zebrafish, cultured cells, and patient-derived mitral valve interstitial cells (MVICs). DCHS1 deficiency in MVICs leads to altered cell migration and cellular patterning.","method":"Morpholino knockdown in zebrafish with rescue experiments (wild-type vs. mutant DCHS1 mRNA), protein stability assays in cultured cells and patient-derived MVICs, Dchs1+/- mouse model","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods across zebrafish, cell culture, patient cells, and mouse models in a single study","pmids":["26258302"],"is_preprint":false},{"year":2015,"finding":"FAT4 acts non-autonomously in the renal stroma to bind DCHS1/DCHS2 in the condensing mesenchyme (cap mesenchyme) to restrict nephron progenitor self-renewal; DCHS1 and its paralog DCHS2 function in a partially redundant fashion, and FAT4 regulation of cap mesenchyme is independent of YAP.","method":"Tissue-specific conditional deletions, Six2-/-;Fat4-/- double mutants, Yap conditional knockout in cap mesenchyme of Fat4-null mice, electron microscopy, gene expression analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — tissue-specific genetics and multiple epistasis experiments establishing pathway position and cell autonomy","pmids":["26116661"],"is_preprint":false},{"year":2015,"finding":"DCHS1 protein localizes in a polarized manner within cap mesenchyme cells, accumulating at the interface with stromal cells, implicating direct interaction with a stromal protein (FAT4); genetically, DCHS1 is required specifically within cap mesenchyme cells for nephron morphogenesis and ureteric bud branching.","method":"Antibody staining of genetic mosaics, tissue-specific genetic analysis, Dchs1 mutant mouse phenotyping","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — polarized localization demonstrated by antibody staining of genetic mosaics with clear functional context","pmids":["26116666"],"is_preprint":false},{"year":2014,"finding":"Fat4 and Dchs1 are expressed in complementary gradients in the hindbrain and are required intrinsically within facial branchiomotor (FBM) neurons and extrinsically within the neuroepithelium for collective tangential neuronal migration and planar cell polarity; Fat-PCP and Fz-PCP regulate FBM neuron migration along orthogonal axes, and disruption of Dchs1 gradients by mosaic inactivation alters FBM neuron polarity and migration.","method":"Mouse genetics (Fat4 and Dchs1 mutants), mosaic inactivation, in vivo neuronal migration assays, PCP marker analysis","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis, mosaic analysis, and multiple functional readouts establishing pathway position and cell autonomy","pmids":["24998526"],"is_preprint":false},{"year":2016,"finding":"The Dchs1-Fat4 planar cell polarity pathway controls cell orientation in early skeletal condensation to define sternum shape via cell intercalation; Fat4 and Dchs1 establish polarized cell behavior intrinsically within the mesenchyme, and alterations in Dchs1-Fat4 activity drive simultaneous narrowing, thickening, and elongation of the sternum.","method":"Dchs1 and Fat4 mutant mouse analysis, cell orientation and intercalation assays in pre-chondrogenic mesenchyme","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — genetic loss-of-function with defined cellular polarity phenotype, first demonstration of Fat4-Dchs1 intrinsic mesenchymal polarity","pmids":["27145737"],"is_preprint":false},{"year":2016,"finding":"Fat4-Dchs1 signaling regulates cell proliferation in the developing vertebrae independently of Yap and Taz; Fat4;Yap and Fat4;Taz double mutant analysis and expression of transcriptional target Ctgf indicate that Fat4-Dchs1 controls sclerotome cell proliferation through a novel Hippo-independent mechanism.","method":"Fat4 and Dchs1 mutant mice, Fat4;Yap and Fat4;Taz double mutants, Ctgf expression analysis, cell polarity and proliferation assays in sclerotome","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with double mutants clearly placing Fat4-Dchs1 independently of Yap/Taz in this context","pmids":["27381226"],"is_preprint":false},{"year":2019,"finding":"Dchs1-Fat4 signaling regulates osteoblast differentiation by suppressing Yap-Tead activity; loss of Dchs1-Fat4 increases Yap-Tead activity and Yap-dependent osteoprogenitor proliferation while delaying differentiation. Yap and Taz differentially regulate Runx2 transcriptional activity, and both Yap-Runx2 and Taz-Runx2 complex activities are altered in Dchs1/Fat4 mutant osteoblasts.","method":"Dchs1/Fat4 mutant mouse analysis, Yap and Taz expression and activity assays, Runx2 transcriptional reporter assays, co-complex analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including transcriptional activity assays and complex analysis in mutant context","pmids":["31358536"],"is_preprint":false},{"year":2022,"finding":"DCHS1-based cell adhesions interact with the septin-actin cytoskeleton through cytoplasmic protein LIX1L (Lix1-Like); the DCHS1-LIX1L-SEPT9 axis interacts with and promotes filamentous actin organization to direct cell-ECM alignment and valve tissue shape.","method":"Biochemical techniques (co-immunoprecipitation, pulldown), mouse and cell culture models, actin organization assays","journal":"Journal of cardiovascular development and disease","confidence":"Medium","confidence_rationale":"Tier 2–3 — biochemical interaction identified with functional consequence in cell culture and mouse models, single lab","pmids":["35200715"],"is_preprint":false},{"year":2025,"finding":"The Fat4 intracellular domain (ICD) controls internalization of Fat4/Dchs1 complexes; removing the Fat4 ICD reduces trans-endocytosis of Dchs1 into Fat4 cells and reduces boundary accumulation of Fat4/Dchs1 complexes. Actin polymerization is required for boundary accumulation of Fat4/Dchs1 complexes but does not correlate with local Fat4/Dchs1 distribution.","method":"Quantitative live imaging of Fat4/Dchs1 complex dynamics, ICD deletion constructs, actin polymerization inhibition","journal":"Biophysical journal","confidence":"Medium","confidence_rationale":"Tier 2 — quantitative live imaging with domain deletion, single lab","pmids":["39955614"],"is_preprint":false},{"year":2025,"finding":"Cx43 S282 phosphorylation upregulates DCHS1 gene expression, which in turn activates YAP phosphorylation and inhibits YAP/TEAD signaling to suppress cardiac fibrosis; DCHS1 acts downstream of phospho-Cx43 and upstream of YAP phosphorylation in this antifibrotic pathway.","method":"mRNA sequencing (GSEA), in vivo angiotensin II cardiac fibrosis model, in vitro TGF-β1 myofibroblast model, lentiviral overexpression and adenoviral injection, Cx43 S282A phosphomutant","journal":"Biochimica et biophysica acta. Molecular cell research","confidence":"Medium","confidence_rationale":"Tier 2–3 — pathway positioning supported by transcriptomics and functional assays, single lab with multiple in vivo and in vitro models","pmids":["39938686"],"is_preprint":false},{"year":2025,"finding":"The DCHS1 intracellular domain (ICD) is required for polarized subcellular localization within the subventricular zone and for Hippo pathway activity; deletion of the ICD reduces pYAP1:YAP1 ratio and increases Ki67+ neuronal proliferation in periventricular regions, causing Van Maldergem-like craniofacial and neurodevelopmental defects.","method":"DCHS1 ICD deletion mouse model (Dchs1Δ), immunostaining, western blotting, pYAP1:YAP1 ratio measurements, Ki67 proliferation assays","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 — ICD deletion mouse model with multiple functional readouts, single lab","pmids":["41972678"],"is_preprint":false},{"year":2025,"finding":"DCHS1 undergoes proteolytic cleavage generating intracellular C-terminal fragments; in cardiac development, DCHS1 displays dynamic subcellular localization shifting from epicardial/endocardial surfaces at earlier embryonic stages to compact myocardium in later fetal and neonatal stages, and forms polarized extensions bridging endothelial and non-myocyte cells.","method":"Dchs1-HA knock-in mouse model, immunohistochemistry, western blotting, single-cell transcriptomics","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 — knock-in mouse model with multiple detection methods revealing proteolytic cleavage and dynamic localization","pmids":["40497950"],"is_preprint":false},{"year":2025,"finding":"A modern human-specific missense mutation in DCHS1 disrupts an N-glycosylation site; introduction of the ancestral (Neanderthal) DCHS1 variant into human iPSCs via CRISPR/Cas9 editing expands striatal progenitors at the expense of neocortical progenitors in neural organoids. EPHA4 (ephrin receptor) is identified as a binding partner of DCHS1, and DCHS1 modulates EPHA4-ephrin signaling.","method":"CRISPR/Cas9 editing of hiPSCs, human cerebral organoids, pulldown/binding partner identification of EPHA4","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — CRISPR editing with organoid functional readout and binding partner identification, preprint with single lab","pmids":["40463223"],"is_preprint":true},{"year":2024,"finding":"DCHS1 neurons derived from patients with periventricular heterotopia show decreased spike threshold due to increased somatic voltage-gated sodium channels; morphological rescue of DCHS1 neurons is achieved by wild-type DCHS1 expression, confirming DCHS1's direct role in neuronal morphology and electrophysiological properties.","method":"Human cerebral organoids from DCHS1 mutation patients, silicon probe recordings, patch-clamp electrophysiology, morphological reconstruction, wild-type DCHS1 rescue expression","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — patch-clamp and rescue experiments in patient-derived organoids, preprint, single lab","pmids":[],"is_preprint":true}],"current_model":"DCHS1 is a large transmembrane protocadherin that functions as a ligand for the FAT4 receptor, forming heterophilic trans-complexes at cell boundaries whose dynamics and internalization are controlled by the Fat4 intracellular domain; this DCHS1-FAT4 signaling axis regulates planar cell polarity and Hippo pathway activity (suppressing YAP/TEAD) across multiple developmental contexts including neurogenesis, kidney development, valve morphogenesis, skeletal patterning, and osteoblast differentiation, with DCHS1's own intracellular domain required for polarized localization and downstream Hippo signaling, and DCHS1 also interacting with the septin-actin cytoskeleton via LIX1L and with the ephrin receptor EPHA4 to regulate cell migration, morphology, and tissue shape."},"narrative":{"teleology":[{"year":2011,"claim":"Establishing that DCHS1 functions as a FAT4 ligand in a conserved signaling pathway resolved the vertebrate identity of the Drosophila Dachsous–Fat system and showed that both genes operate in the same pathway across multiple organs.","evidence":"Gene-targeted mouse mutants for Dchs1 and Fat4, with single and double mutant phenotypic comparison and reciprocal protein staining","pmids":["21303848"],"confidence":"High","gaps":["Biochemical demonstration of direct DCHS1–FAT4 binding was not provided","Downstream signaling effectors were not identified"]},{"year":2013,"claim":"Placing DCHS1–FAT4 upstream of YAP in genetic epistasis established that this protocadherin pair signals through the Hippo pathway to control neural progenitor proliferation and differentiation.","evidence":"Concurrent Yap knockdown rescued the increased progenitor numbers caused by Dchs1/Fat4 loss in mouse neuroepithelium","pmids":["24056717"],"confidence":"High","gaps":["Biochemical mechanism linking DCHS1–FAT4 to YAP phosphorylation was not defined","Whether Hippo dependence is universal across all DCHS1-dependent tissues was unknown"]},{"year":2014,"claim":"Demonstrating that Fat4 and Dchs1 are expressed in complementary gradients and required for collective neuronal migration revealed that DCHS1–FAT4 provides graded planar polarity cues distinct from Frizzled-PCP.","evidence":"Mouse genetics with mosaic inactivation and in vivo neuronal migration assays in hindbrain facial branchiomotor neurons","pmids":["24998526"],"confidence":"High","gaps":["How DCHS1 gradient information is transduced intracellularly to orient migration was not resolved"]},{"year":2015,"claim":"Identifying DCHS1 mutations as causative for familial mitral valve prolapse linked this protocadherin to human cardiovascular disease and showed that missense mutations reduce protein stability.","evidence":"Zebrafish morpholino knockdown with rescue, protein stability assays in patient-derived MVICs, and Dchs1+/- mouse model","pmids":["26258302"],"confidence":"High","gaps":["Precise structural basis for reduced protein stability was not determined","Whether valve disease arises from impaired FAT4 binding or impaired intracellular signaling was unclear"]},{"year":2015,"claim":"Tissue-specific deletion studies in the kidney established that DCHS1 localizes in a polarized manner at the stromal–cap mesenchyme interface and acts cell-autonomously in cap mesenchyme, while FAT4 acts non-autonomously from the stroma — and that this renal function can be YAP-independent.","evidence":"Conditional deletions, double mutant epistasis with Yap in cap mesenchyme, antibody staining of genetic mosaics in mouse kidney","pmids":["26116661","26116666"],"confidence":"High","gaps":["The alternative downstream effector in the YAP-independent renal pathway was not identified","Whether DCHS1 and DCHS2 are fully redundant in cap mesenchyme was not resolved"]},{"year":2016,"claim":"Studies of sternum and vertebral morphogenesis showed that DCHS1–FAT4 directs cell orientation and intercalation in mesenchymal condensations, and that in the sclerotome it regulates proliferation independently of YAP and TAZ, revealing context-dependent effector usage.","evidence":"Dchs1/Fat4 mutant mice with cell orientation assays in pre-chondrogenic mesenchyme; Fat4;Yap and Fat4;Taz double mutant analysis in sclerotome","pmids":["27145737","27381226"],"confidence":"High","gaps":["The Hippo-independent effector downstream of DCHS1–FAT4 in sclerotome was not identified","Molecular link between DCHS1 and cytoskeletal remodeling underlying cell intercalation was not defined"]},{"year":2019,"claim":"Demonstrating that DCHS1–FAT4 loss elevates YAP-TEAD activity and differentially alters YAP–Runx2 and TAZ–Runx2 complexes in osteoblasts provided the first mechanistic link between this pathway and a lineage-specific transcription factor.","evidence":"Dchs1/Fat4 mutant mouse osteoblast analysis with Runx2 transcriptional reporter assays and co-complex analysis","pmids":["31358536"],"confidence":"High","gaps":["Whether DCHS1 directly regulates LATS kinase activity was not tested","Structural basis of YAP–Runx2 versus TAZ–Runx2 differential regulation was not resolved"]},{"year":2022,"claim":"Identification of LIX1L as a cytoplasmic adaptor linking the DCHS1 intracellular domain to septins and actin provided the first molecular bridge between DCHS1 adhesion and cytoskeletal organization in valve tissue.","evidence":"Co-immunoprecipitation and pulldown with actin organization assays in mouse and cell culture models","pmids":["35200715"],"confidence":"Medium","gaps":["Interaction has not been independently confirmed by a second laboratory","Whether the DCHS1–LIX1L–SEPT9 axis functions outside cardiac valve tissue is unknown","Direct binding stoichiometry and structural details are lacking"]},{"year":2025,"claim":"Multiple 2025 studies defined the functional importance of the DCHS1 intracellular domain: it is required for polarized localization and Hippo signaling in the brain, undergoes proteolytic cleavage during cardiac development, and its trans-complex dynamics with FAT4 are controlled by the Fat4 ICD and actin polymerization.","evidence":"DCHS1 ICD deletion mouse model with pYAP1:YAP1 ratio measurements; Dchs1-HA knock-in mouse with western blotting revealing cleavage fragments; quantitative live imaging of Fat4/Dchs1 complexes with Fat4 ICD deletion and actin inhibition","pmids":["41972678","40497950","39955614"],"confidence":"Medium","gaps":["Identity of the protease(s) cleaving DCHS1 is unknown","Whether DCHS1 cleavage fragments have signaling functions remains untested","How Fat4 ICD-dependent trans-endocytosis of DCHS1 connects to downstream Hippo effectors is not established"]},{"year":2025,"claim":"Phospho-Cx43 (S282) was shown to upregulate DCHS1 transcription, placing DCHS1 downstream of gap junction signaling and upstream of YAP phosphorylation in an antifibrotic cardiac pathway.","evidence":"mRNA sequencing, angiotensin II cardiac fibrosis model in vivo, TGF-β1 myofibroblast model in vitro, Cx43 S282A phosphomutant","pmids":["39938686"],"confidence":"Medium","gaps":["Mechanism by which Cx43 phosphorylation regulates DCHS1 transcription is unknown","Whether this pathway operates outside the cardiac fibrosis context is untested","Single-laboratory finding not yet independently replicated"]},{"year":null,"claim":"Key unresolved questions include the identity of the protease(s) that cleave DCHS1, the signaling function (if any) of DCHS1 cleavage fragments, the molecular mechanism linking DCHS1–FAT4 to LATS kinase activation, and the nature of the Hippo-independent downstream effector operating in certain tissues.","evidence":"","pmids":[],"confidence":"High","gaps":["No structural model of the DCHS1–FAT4 interface exists","The Hippo-independent effector downstream of DCHS1–FAT4 in sclerotome and kidney remains unidentified","Whether DCHS1 proteolytic fragments function as transcriptional regulators is untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[0,4,6,10]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,8,11,12]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,4,10,13]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[9]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,3,8,11,12]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,4,5,6,7,8,13]}],"complexes":[],"partners":["FAT4","LIX1L","SEPT9","YAP1","EPHA4"],"other_free_text":[]},"mechanistic_narrative":"DCHS1 is a large transmembrane protocadherin that functions as a ligand for the FAT4 receptor, forming heterophilic trans-complexes at cell boundaries to regulate planar cell polarity, Hippo pathway activity, and tissue morphogenesis across multiple developmental contexts. DCHS1–FAT4 signaling suppresses YAP/TEAD transcriptional activity to control progenitor proliferation and differentiation in the neuroepithelium, kidney, bone, and cardiac valves, though in certain contexts such as the sclerotome it regulates proliferation independently of YAP/TAZ [PMID:21303848, PMID:24056717, PMID:27381226, PMID:31358536]. The DCHS1 intracellular domain is required for polarized subcellular localization and downstream Hippo signaling, and DCHS1 undergoes proteolytic cleavage generating intracellular C-terminal fragments with dynamic tissue-specific localization during cardiac development [PMID:41972678, PMID:40497950]. Loss-of-function mutations in DCHS1 cause mitral valve prolapse by reducing protein stability and disrupting cell migration, and deletion of the intracellular domain produces Van Maldergem-like craniofacial and neurodevelopmental defects [PMID:26258302, PMID:41972678]."},"prefetch_data":{"uniprot":{"accession":"Q96JQ0","full_name":"Protocadherin-16","aliases":["Cadherin-19","Cadherin-25","Fibroblast cadherin-1","Protein dachsous homolog 1"],"length_aa":3298,"mass_kda":346.2,"function":"Calcium-dependent cell-adhesion protein. Mediates functions in neuroprogenitor cell proliferation and differentiation. In the heart, has a critical role for proper morphogenesis of the mitral valve, acting in the regulation of cell migration involved in valve formation (PubMed:26258302)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q96JQ0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DCHS1","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DCHS1","total_profiled":1310},"omim":[{"mim_id":"619701","title":"YOON-BELLEN NEURODEVELOPMENTAL SYNDROME; YOBELN","url":"https://www.omim.org/entry/619701"},{"mim_id":"617513","title":"OXOGLUTARATE DEHYDROGENASE-LIKE PROTEIN; OGDHL","url":"https://www.omim.org/entry/617513"},{"mim_id":"615546","title":"VAN MALDERGEM SYNDROME 2; VMLDS2","url":"https://www.omim.org/entry/615546"},{"mim_id":"612411","title":"FAT ATYPICAL CADHERIN 4; FAT4","url":"https://www.omim.org/entry/612411"},{"mim_id":"607829","title":"MITRAL VALVE PROLAPSE 2; MVP2","url":"https://www.omim.org/entry/607829"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DCHS1"},"hgnc":{"alias_symbol":["FIB1","KIAA1773","FLJ11790","CDHR6"],"prev_symbol":["CDH25","PCDH16"]},"alphafold":{"accession":"Q96JQ0","domains":[],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96JQ0","model_url":"","pae_url":"","plddt_mean":null},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DCHS1","jax_strain_url":"https://www.jax.org/strain/search?query=DCHS1"},"sequence":{"accession":"Q96JQ0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96JQ0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96JQ0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96JQ0"}},"corpus_meta":[{"pmid":"24056717","id":"PMC_24056717","title":"Mutations in genes encoding the cadherin receptor-ligand pair DCHS1 and FAT4 disrupt cerebral cortical development.","date":"2013","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24056717","citation_count":213,"is_preprint":false},{"pmid":"21303848","id":"PMC_21303848","title":"Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-Fat4 signaling during mammalian development.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21303848","citation_count":167,"is_preprint":false},{"pmid":"26258302","id":"PMC_26258302","title":"Mutations in DCHS1 cause mitral valve prolapse.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26258302","citation_count":157,"is_preprint":false},{"pmid":"26116661","id":"PMC_26116661","title":"Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26116661","citation_count":74,"is_preprint":false},{"pmid":"16059920","id":"PMC_16059920","title":"Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.","date":"2005","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16059920","citation_count":74,"is_preprint":false},{"pmid":"26116666","id":"PMC_26116666","title":"Fat4/Dchs1 signaling between stromal and cap mesenchyme cells influences nephrogenesis and ureteric bud branching.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26116666","citation_count":63,"is_preprint":false},{"pmid":"24998526","id":"PMC_24998526","title":"Regulation of neuronal migration by Dchs1-Fat4 planar cell polarity.","date":"2014","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/24998526","citation_count":61,"is_preprint":false},{"pmid":"27145737","id":"PMC_27145737","title":"Dchs1-Fat4 regulation of polarized cell behaviours during skeletal morphogenesis.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27145737","citation_count":43,"is_preprint":false},{"pmid":"31358536","id":"PMC_31358536","title":"Dchs1-Fat4 regulation of osteogenic differentiation in mouse.","date":"2019","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31358536","citation_count":28,"is_preprint":false},{"pmid":"27381226","id":"PMC_27381226","title":"Fat4-Dchs1 signalling controls cell proliferation in developing vertebrae.","date":"2016","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27381226","citation_count":26,"is_preprint":false},{"pmid":"29224215","id":"PMC_29224215","title":"Deleterious variants in DCHS1 are prevalent in sporadic cases of mitral valve prolapse.","date":"2017","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29224215","citation_count":13,"is_preprint":false},{"pmid":"35200715","id":"PMC_35200715","title":"DCHS1, Lix1L, and the Septin Cytoskeleton: Molecular and Developmental Etiology of Mitral Valve Prolapse.","date":"2022","source":"Journal of cardiovascular development and disease","url":"https://pubmed.ncbi.nlm.nih.gov/35200715","citation_count":10,"is_preprint":false},{"pmid":"39196305","id":"PMC_39196305","title":"A high-calcium environment induced ectopic calcification of renal interstitial fibroblasts via TFPI-2-DCHS1-ALP/ENPP1 axis to participate in Randall's plaque formation.","date":"2024","source":"Urolithiasis","url":"https://pubmed.ncbi.nlm.nih.gov/39196305","citation_count":5,"is_preprint":false},{"pmid":"37399314","id":"PMC_37399314","title":"Mutation in mitral valve prolapse susceptible gene DCHS1 causes familial mitral annular disjunction.","date":"2024","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37399314","citation_count":4,"is_preprint":false},{"pmid":"32295462","id":"PMC_32295462","title":"DCHS1 DNA copy number loss associated with pediatric urinary tract infection risk.","date":"2020","source":"Innate immunity","url":"https://pubmed.ncbi.nlm.nih.gov/32295462","citation_count":3,"is_preprint":false},{"pmid":"39938686","id":"PMC_39938686","title":"Connexin 43 dephosphorylation mediates the Dchs1/YAP/TEAD signaling pathway to induce cardiac fibrosis.","date":"2025","source":"Biochimica et biophysica acta. Molecular cell research","url":"https://pubmed.ncbi.nlm.nih.gov/39938686","citation_count":2,"is_preprint":false},{"pmid":"39955614","id":"PMC_39955614","title":"Fat4 intracellular domain controls internalization of Fat4/Dchs1 planar polarity membrane complexes.","date":"2025","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/39955614","citation_count":2,"is_preprint":false},{"pmid":"36434174","id":"PMC_36434174","title":"Neonatal lethality of mouse A/J-7SM consomic strain is caused by an insertion mutation in the Dchs1 gene.","date":"2022","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/36434174","citation_count":1,"is_preprint":false},{"pmid":"40497950","id":"PMC_40497950","title":"Dynamic Expression and Functional Implications of the Cell Polarity Gene, Dchs1, During Cardiac Development.","date":"2025","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/40497950","citation_count":1,"is_preprint":false},{"pmid":"40463223","id":"PMC_40463223","title":"DCHS1 Modulates Forebrain Proportions in Modern Humans via a Glycosylation Change.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40463223","citation_count":1,"is_preprint":false},{"pmid":"41972678","id":"PMC_41972678","title":"Loss of the DCHS1 Intracellular Domain Expands Neurogenic Proliferation and Generates Van Maldergem-like Neurodevelopmental Defects.","date":"2026","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/41972678","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.05.25.595882","title":"The Fat4 intracellular domain controls turnover of Fat4/Dchs1 planar polarity membrane complexes","date":"2024-05-30","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.25.595882","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.10.602948","title":"Neuronal Hyperactivity in Neurons Derived from Individuals with Grey Matter Heterotopia","date":"2024-07-10","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.10.602948","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":12920,"output_tokens":4021,"usd":0.049537},"stage2":{"model":"claude-opus-4-6","input_tokens":7440,"output_tokens":2972,"usd":0.16725},"total_usd":0.216787,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"DCHS1 functions as a ligand for FAT4 receptor in a conserved intercellular signaling pathway regulating planar cell polarity and Hippo signaling; Dchs1 and Fat4 single mutants and double mutants have similar phenotypes throughout multiple organs, and mutation of either gene increases protein staining for the other, consistent with a ligand-receptor relationship.\",\n      \"method\": \"Gene-targeted mutation in mice, phenotypic comparison of single and double mutants, protein staining\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal genetic and protein evidence across multiple organs, replicated in multiple subsequent studies\",\n      \"pmids\": [\"21303848\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"DCHS1 and FAT4 act upstream of YAP (a transcriptional effector of the Hippo signaling pathway) to regulate neural progenitor proliferation and differentiation; concurrent knockdown of Yap countered the increased progenitor numbers and reduced differentiation caused by Dchs1/Fat4 knockdown in mouse neuroepithelium.\",\n      \"method\": \"Genetic epistasis (concurrent knockdown of Yap rescues Dchs1/Fat4 loss-of-function phenotype), mouse embryonic neuroepithelium knockdown\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with clear phenotypic rescue, replicated across human and mouse models\",\n      \"pmids\": [\"24056717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DCHS1 mutations reduce protein stability; missense mutations in DCHS1 segregating with mitral valve prolapse (MVP) result in reduced DCHS1 protein levels in zebrafish, cultured cells, and patient-derived mitral valve interstitial cells (MVICs). DCHS1 deficiency in MVICs leads to altered cell migration and cellular patterning.\",\n      \"method\": \"Morpholino knockdown in zebrafish with rescue experiments (wild-type vs. mutant DCHS1 mRNA), protein stability assays in cultured cells and patient-derived MVICs, Dchs1+/- mouse model\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods across zebrafish, cell culture, patient cells, and mouse models in a single study\",\n      \"pmids\": [\"26258302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"FAT4 acts non-autonomously in the renal stroma to bind DCHS1/DCHS2 in the condensing mesenchyme (cap mesenchyme) to restrict nephron progenitor self-renewal; DCHS1 and its paralog DCHS2 function in a partially redundant fashion, and FAT4 regulation of cap mesenchyme is independent of YAP.\",\n      \"method\": \"Tissue-specific conditional deletions, Six2-/-;Fat4-/- double mutants, Yap conditional knockout in cap mesenchyme of Fat4-null mice, electron microscopy, gene expression analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific genetics and multiple epistasis experiments establishing pathway position and cell autonomy\",\n      \"pmids\": [\"26116661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DCHS1 protein localizes in a polarized manner within cap mesenchyme cells, accumulating at the interface with stromal cells, implicating direct interaction with a stromal protein (FAT4); genetically, DCHS1 is required specifically within cap mesenchyme cells for nephron morphogenesis and ureteric bud branching.\",\n      \"method\": \"Antibody staining of genetic mosaics, tissue-specific genetic analysis, Dchs1 mutant mouse phenotyping\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — polarized localization demonstrated by antibody staining of genetic mosaics with clear functional context\",\n      \"pmids\": [\"26116666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Fat4 and Dchs1 are expressed in complementary gradients in the hindbrain and are required intrinsically within facial branchiomotor (FBM) neurons and extrinsically within the neuroepithelium for collective tangential neuronal migration and planar cell polarity; Fat-PCP and Fz-PCP regulate FBM neuron migration along orthogonal axes, and disruption of Dchs1 gradients by mosaic inactivation alters FBM neuron polarity and migration.\",\n      \"method\": \"Mouse genetics (Fat4 and Dchs1 mutants), mosaic inactivation, in vivo neuronal migration assays, PCP marker analysis\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis, mosaic analysis, and multiple functional readouts establishing pathway position and cell autonomy\",\n      \"pmids\": [\"24998526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"The Dchs1-Fat4 planar cell polarity pathway controls cell orientation in early skeletal condensation to define sternum shape via cell intercalation; Fat4 and Dchs1 establish polarized cell behavior intrinsically within the mesenchyme, and alterations in Dchs1-Fat4 activity drive simultaneous narrowing, thickening, and elongation of the sternum.\",\n      \"method\": \"Dchs1 and Fat4 mutant mouse analysis, cell orientation and intercalation assays in pre-chondrogenic mesenchyme\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic loss-of-function with defined cellular polarity phenotype, first demonstration of Fat4-Dchs1 intrinsic mesenchymal polarity\",\n      \"pmids\": [\"27145737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Fat4-Dchs1 signaling regulates cell proliferation in the developing vertebrae independently of Yap and Taz; Fat4;Yap and Fat4;Taz double mutant analysis and expression of transcriptional target Ctgf indicate that Fat4-Dchs1 controls sclerotome cell proliferation through a novel Hippo-independent mechanism.\",\n      \"method\": \"Fat4 and Dchs1 mutant mice, Fat4;Yap and Fat4;Taz double mutants, Ctgf expression analysis, cell polarity and proliferation assays in sclerotome\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with double mutants clearly placing Fat4-Dchs1 independently of Yap/Taz in this context\",\n      \"pmids\": [\"27381226\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Dchs1-Fat4 signaling regulates osteoblast differentiation by suppressing Yap-Tead activity; loss of Dchs1-Fat4 increases Yap-Tead activity and Yap-dependent osteoprogenitor proliferation while delaying differentiation. Yap and Taz differentially regulate Runx2 transcriptional activity, and both Yap-Runx2 and Taz-Runx2 complex activities are altered in Dchs1/Fat4 mutant osteoblasts.\",\n      \"method\": \"Dchs1/Fat4 mutant mouse analysis, Yap and Taz expression and activity assays, Runx2 transcriptional reporter assays, co-complex analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including transcriptional activity assays and complex analysis in mutant context\",\n      \"pmids\": [\"31358536\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"DCHS1-based cell adhesions interact with the septin-actin cytoskeleton through cytoplasmic protein LIX1L (Lix1-Like); the DCHS1-LIX1L-SEPT9 axis interacts with and promotes filamentous actin organization to direct cell-ECM alignment and valve tissue shape.\",\n      \"method\": \"Biochemical techniques (co-immunoprecipitation, pulldown), mouse and cell culture models, actin organization assays\",\n      \"journal\": \"Journal of cardiovascular development and disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — biochemical interaction identified with functional consequence in cell culture and mouse models, single lab\",\n      \"pmids\": [\"35200715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The Fat4 intracellular domain (ICD) controls internalization of Fat4/Dchs1 complexes; removing the Fat4 ICD reduces trans-endocytosis of Dchs1 into Fat4 cells and reduces boundary accumulation of Fat4/Dchs1 complexes. Actin polymerization is required for boundary accumulation of Fat4/Dchs1 complexes but does not correlate with local Fat4/Dchs1 distribution.\",\n      \"method\": \"Quantitative live imaging of Fat4/Dchs1 complex dynamics, ICD deletion constructs, actin polymerization inhibition\",\n      \"journal\": \"Biophysical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — quantitative live imaging with domain deletion, single lab\",\n      \"pmids\": [\"39955614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cx43 S282 phosphorylation upregulates DCHS1 gene expression, which in turn activates YAP phosphorylation and inhibits YAP/TEAD signaling to suppress cardiac fibrosis; DCHS1 acts downstream of phospho-Cx43 and upstream of YAP phosphorylation in this antifibrotic pathway.\",\n      \"method\": \"mRNA sequencing (GSEA), in vivo angiotensin II cardiac fibrosis model, in vitro TGF-β1 myofibroblast model, lentiviral overexpression and adenoviral injection, Cx43 S282A phosphomutant\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — pathway positioning supported by transcriptomics and functional assays, single lab with multiple in vivo and in vitro models\",\n      \"pmids\": [\"39938686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The DCHS1 intracellular domain (ICD) is required for polarized subcellular localization within the subventricular zone and for Hippo pathway activity; deletion of the ICD reduces pYAP1:YAP1 ratio and increases Ki67+ neuronal proliferation in periventricular regions, causing Van Maldergem-like craniofacial and neurodevelopmental defects.\",\n      \"method\": \"DCHS1 ICD deletion mouse model (Dchs1Δ), immunostaining, western blotting, pYAP1:YAP1 ratio measurements, Ki67 proliferation assays\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ICD deletion mouse model with multiple functional readouts, single lab\",\n      \"pmids\": [\"41972678\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"DCHS1 undergoes proteolytic cleavage generating intracellular C-terminal fragments; in cardiac development, DCHS1 displays dynamic subcellular localization shifting from epicardial/endocardial surfaces at earlier embryonic stages to compact myocardium in later fetal and neonatal stages, and forms polarized extensions bridging endothelial and non-myocyte cells.\",\n      \"method\": \"Dchs1-HA knock-in mouse model, immunohistochemistry, western blotting, single-cell transcriptomics\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — knock-in mouse model with multiple detection methods revealing proteolytic cleavage and dynamic localization\",\n      \"pmids\": [\"40497950\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A modern human-specific missense mutation in DCHS1 disrupts an N-glycosylation site; introduction of the ancestral (Neanderthal) DCHS1 variant into human iPSCs via CRISPR/Cas9 editing expands striatal progenitors at the expense of neocortical progenitors in neural organoids. EPHA4 (ephrin receptor) is identified as a binding partner of DCHS1, and DCHS1 modulates EPHA4-ephrin signaling.\",\n      \"method\": \"CRISPR/Cas9 editing of hiPSCs, human cerebral organoids, pulldown/binding partner identification of EPHA4\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR editing with organoid functional readout and binding partner identification, preprint with single lab\",\n      \"pmids\": [\"40463223\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DCHS1 neurons derived from patients with periventricular heterotopia show decreased spike threshold due to increased somatic voltage-gated sodium channels; morphological rescue of DCHS1 neurons is achieved by wild-type DCHS1 expression, confirming DCHS1's direct role in neuronal morphology and electrophysiological properties.\",\n      \"method\": \"Human cerebral organoids from DCHS1 mutation patients, silicon probe recordings, patch-clamp electrophysiology, morphological reconstruction, wild-type DCHS1 rescue expression\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — patch-clamp and rescue experiments in patient-derived organoids, preprint, single lab\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"DCHS1 is a large transmembrane protocadherin that functions as a ligand for the FAT4 receptor, forming heterophilic trans-complexes at cell boundaries whose dynamics and internalization are controlled by the Fat4 intracellular domain; this DCHS1-FAT4 signaling axis regulates planar cell polarity and Hippo pathway activity (suppressing YAP/TEAD) across multiple developmental contexts including neurogenesis, kidney development, valve morphogenesis, skeletal patterning, and osteoblast differentiation, with DCHS1's own intracellular domain required for polarized localization and downstream Hippo signaling, and DCHS1 also interacting with the septin-actin cytoskeleton via LIX1L and with the ephrin receptor EPHA4 to regulate cell migration, morphology, and tissue shape.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DCHS1 is a large transmembrane protocadherin that functions as a ligand for the FAT4 receptor, forming heterophilic trans-complexes at cell boundaries to regulate planar cell polarity, Hippo pathway activity, and tissue morphogenesis across multiple developmental contexts. DCHS1–FAT4 signaling suppresses YAP/TEAD transcriptional activity to control progenitor proliferation and differentiation in the neuroepithelium, kidney, bone, and cardiac valves, though in certain contexts such as the sclerotome it regulates proliferation independently of YAP/TAZ [PMID:21303848, PMID:24056717, PMID:27381226, PMID:31358536]. The DCHS1 intracellular domain is required for polarized subcellular localization and downstream Hippo signaling, and DCHS1 undergoes proteolytic cleavage generating intracellular C-terminal fragments with dynamic tissue-specific localization during cardiac development [PMID:41972678, PMID:40497950]. Loss-of-function mutations in DCHS1 cause mitral valve prolapse by reducing protein stability and disrupting cell migration, and deletion of the intracellular domain produces Van Maldergem-like craniofacial and neurodevelopmental defects [PMID:26258302, PMID:41972678].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"Establishing that DCHS1 functions as a FAT4 ligand in a conserved signaling pathway resolved the vertebrate identity of the Drosophila Dachsous–Fat system and showed that both genes operate in the same pathway across multiple organs.\",\n      \"evidence\": \"Gene-targeted mouse mutants for Dchs1 and Fat4, with single and double mutant phenotypic comparison and reciprocal protein staining\",\n      \"pmids\": [\"21303848\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Biochemical demonstration of direct DCHS1–FAT4 binding was not provided\",\n        \"Downstream signaling effectors were not identified\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Placing DCHS1–FAT4 upstream of YAP in genetic epistasis established that this protocadherin pair signals through the Hippo pathway to control neural progenitor proliferation and differentiation.\",\n      \"evidence\": \"Concurrent Yap knockdown rescued the increased progenitor numbers caused by Dchs1/Fat4 loss in mouse neuroepithelium\",\n      \"pmids\": [\"24056717\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Biochemical mechanism linking DCHS1–FAT4 to YAP phosphorylation was not defined\",\n        \"Whether Hippo dependence is universal across all DCHS1-dependent tissues was unknown\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating that Fat4 and Dchs1 are expressed in complementary gradients and required for collective neuronal migration revealed that DCHS1–FAT4 provides graded planar polarity cues distinct from Frizzled-PCP.\",\n      \"evidence\": \"Mouse genetics with mosaic inactivation and in vivo neuronal migration assays in hindbrain facial branchiomotor neurons\",\n      \"pmids\": [\"24998526\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How DCHS1 gradient information is transduced intracellularly to orient migration was not resolved\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identifying DCHS1 mutations as causative for familial mitral valve prolapse linked this protocadherin to human cardiovascular disease and showed that missense mutations reduce protein stability.\",\n      \"evidence\": \"Zebrafish morpholino knockdown with rescue, protein stability assays in patient-derived MVICs, and Dchs1+/- mouse model\",\n      \"pmids\": [\"26258302\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Precise structural basis for reduced protein stability was not determined\",\n        \"Whether valve disease arises from impaired FAT4 binding or impaired intracellular signaling was unclear\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Tissue-specific deletion studies in the kidney established that DCHS1 localizes in a polarized manner at the stromal–cap mesenchyme interface and acts cell-autonomously in cap mesenchyme, while FAT4 acts non-autonomously from the stroma — and that this renal function can be YAP-independent.\",\n      \"evidence\": \"Conditional deletions, double mutant epistasis with Yap in cap mesenchyme, antibody staining of genetic mosaics in mouse kidney\",\n      \"pmids\": [\"26116661\", \"26116666\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The alternative downstream effector in the YAP-independent renal pathway was not identified\",\n        \"Whether DCHS1 and DCHS2 are fully redundant in cap mesenchyme was not resolved\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Studies of sternum and vertebral morphogenesis showed that DCHS1–FAT4 directs cell orientation and intercalation in mesenchymal condensations, and that in the sclerotome it regulates proliferation independently of YAP and TAZ, revealing context-dependent effector usage.\",\n      \"evidence\": \"Dchs1/Fat4 mutant mice with cell orientation assays in pre-chondrogenic mesenchyme; Fat4;Yap and Fat4;Taz double mutant analysis in sclerotome\",\n      \"pmids\": [\"27145737\", \"27381226\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The Hippo-independent effector downstream of DCHS1–FAT4 in sclerotome was not identified\",\n        \"Molecular link between DCHS1 and cytoskeletal remodeling underlying cell intercalation was not defined\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrating that DCHS1–FAT4 loss elevates YAP-TEAD activity and differentially alters YAP–Runx2 and TAZ–Runx2 complexes in osteoblasts provided the first mechanistic link between this pathway and a lineage-specific transcription factor.\",\n      \"evidence\": \"Dchs1/Fat4 mutant mouse osteoblast analysis with Runx2 transcriptional reporter assays and co-complex analysis\",\n      \"pmids\": [\"31358536\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether DCHS1 directly regulates LATS kinase activity was not tested\",\n        \"Structural basis of YAP–Runx2 versus TAZ–Runx2 differential regulation was not resolved\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identification of LIX1L as a cytoplasmic adaptor linking the DCHS1 intracellular domain to septins and actin provided the first molecular bridge between DCHS1 adhesion and cytoskeletal organization in valve tissue.\",\n      \"evidence\": \"Co-immunoprecipitation and pulldown with actin organization assays in mouse and cell culture models\",\n      \"pmids\": [\"35200715\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Interaction has not been independently confirmed by a second laboratory\",\n        \"Whether the DCHS1–LIX1L–SEPT9 axis functions outside cardiac valve tissue is unknown\",\n        \"Direct binding stoichiometry and structural details are lacking\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Multiple 2025 studies defined the functional importance of the DCHS1 intracellular domain: it is required for polarized localization and Hippo signaling in the brain, undergoes proteolytic cleavage during cardiac development, and its trans-complex dynamics with FAT4 are controlled by the Fat4 ICD and actin polymerization.\",\n      \"evidence\": \"DCHS1 ICD deletion mouse model with pYAP1:YAP1 ratio measurements; Dchs1-HA knock-in mouse with western blotting revealing cleavage fragments; quantitative live imaging of Fat4/Dchs1 complexes with Fat4 ICD deletion and actin inhibition\",\n      \"pmids\": [\"41972678\", \"40497950\", \"39955614\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Identity of the protease(s) cleaving DCHS1 is unknown\",\n        \"Whether DCHS1 cleavage fragments have signaling functions remains untested\",\n        \"How Fat4 ICD-dependent trans-endocytosis of DCHS1 connects to downstream Hippo effectors is not established\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Phospho-Cx43 (S282) was shown to upregulate DCHS1 transcription, placing DCHS1 downstream of gap junction signaling and upstream of YAP phosphorylation in an antifibrotic cardiac pathway.\",\n      \"evidence\": \"mRNA sequencing, angiotensin II cardiac fibrosis model in vivo, TGF-β1 myofibroblast model in vitro, Cx43 S282A phosphomutant\",\n      \"pmids\": [\"39938686\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which Cx43 phosphorylation regulates DCHS1 transcription is unknown\",\n        \"Whether this pathway operates outside the cardiac fibrosis context is untested\",\n        \"Single-laboratory finding not yet independently replicated\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of the protease(s) that cleave DCHS1, the signaling function (if any) of DCHS1 cleavage fragments, the molecular mechanism linking DCHS1–FAT4 to LATS kinase activation, and the nature of the Hippo-independent downstream effector operating in certain tissues.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No structural model of the DCHS1–FAT4 interface exists\",\n        \"The Hippo-independent effector downstream of DCHS1–FAT4 in sclerotome and kidney remains unidentified\",\n        \"Whether DCHS1 proteolytic fragments function as transcriptional regulators is untested\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [0, 4, 6, 10]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 8, 11, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 4, 10, 13]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 3, 8, 11, 12]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 4, 5, 6, 7, 8, 13]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"FAT4\",\n      \"LIX1L\",\n      \"SEPT9\",\n      \"YAP1\",\n      \"EPHA4\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}